N-nitrosoguvacine
- CAS NO.：55557-01-2
- Empirical Formula: C6H8N2O3
- Molecular Weight: 156.14
- SAFETY DATA SHEET (SDS)
- Update Date: 2026-05-27 17:18:02
What is N-nitrosoguvacine?
The Uses of N-nitrosoguvacine
N-Nitrosoguvacine is a carcinogenic agent shown as a causative agent for oral cancer. An causative alkaloid agent present in the Areca nut.
Definition
ChEBI: N-Nitrosoguvacine is a citraconoyl group.
Properties of N-nitrosoguvacine
| Melting point: | >121°C (dec.) |
| storage temp. | Amber Vial, -20°C Freezer, Under inert atmosphere |
| solubility | DMSO (Slightly), Methanol (Slightly, Heated) |
| form | Solid |
| color | Pale Yellow to Pale Beige |
| Stability: | Light sensitive |
| IARC | 3 (Vol. Sup 7, 85) 2004 |
Safety information for N-nitrosoguvacine
Computed Descriptors for N-nitrosoguvacine
New Products
2-(2-Chlorophenyl)glycine Propiolic Acid 1-(3-Hydroxy-4-methoxyphenyl)-2-nitroethene (±)-amino(2-fluorophenyl)acetic acid trans-3-Benzyloxy-4-methoxy-beta-nitrostyrene 1-Pentadecanol 4-(4-Αminophenyl)-3-Morpholinone 3-Morpholino-1-(4-(2-oxopiperidin-1-yl) phenyl)-5,6-dihyropyridin-2-(1H)-one 1-(4-Aminophenyl)-3-morpholino-5,6-dihydropyridin-2(1H)-one N-cyanoacetylurethane 1H-IndazoleRelated products of tetrahydrofuran
You may like
-
40216-83-9 trans-4-Hydroxy-L-proline methyl ester hydrochloride 98+View Details
40216-83-9 -
471-25-0 Propiolic Acid 98+View Details
471-25-0 -
84145-28-8 98+View Details
84145-28-8 -
trans-3-Benzyloxy-4-methoxy-beta-nitrostyrene 98+View Details
63909-29-5 -
2-(2-Chlorophenyl)glycine 88744-36-9 98+View Details
88744-36-9 -
40216-83-9 trans-4-Hydroxy-L-proline methyl ester hydrochloride 98+View Details
40216-83-9 -
629-76-5 98+View Details
629-76-5 -
1-(3-Hydroxy-4-methoxyphenyl)-2-nitroethene 98+View Details
39816-35-8
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.